Letter: ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19

Ralley E. Prentice, Doug Tjandra, Mayur Garg, John S. Lubel, Spiros Fourlanos, Doug Johnson, Aysha Al-Ani, Britt Christensen

Research output: Contribution to journalLetterOtherpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)1422-1423
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Issue number8
Publication statusPublished - 1 Oct 2020

Cite this